Li Shi-Yu, Ding Yan
Department of Pediatric Immunology, Wuhan Children's Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430016, China.
Zhongguo Dang Dai Er Ke Za Zhi. 2023 Mar 15;25(3):244-249. doi: 10.7499/j.issn.1008-8830.2210151.
To study the expression of interleukin-17A (IL-17A) in the serum of children with intravenous immunoglobulin (IVIG)-resistant Kawasaki disease (KD) and its clinical significance.
A total of 143 children with KD who were hospitalized in Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, from June 2021 to June 2022 were enrolled in this prospective study, among whom 115 had IVIG-sensitive KD and 28 had IVIG-resistant KD. After matching for sex and age, 110 children with acute respiratory infectious diseases (fever time ≥5 days but without KD) were enrolled as the control group. The enzyme-linked immunosorbent assay was used to measure the serum level of IL-17A. The levels of white blood cell count (WBC), neutrophil count (NE), platelet count, erythrocyte sedimentation rate, and C-reactive protein (CRP) were measured. The receiver operating characteristic curve was plotted to analyze the value of WBC, NE, CRP, and IL-17A in the prediction of IVIG-resistant KD. The multivariate logistic regression analysis was used to evaluate the predictive factors for resistance to IVIG in children with KD.
Before IVIG treatment, the KD group had a significantly higher serum level of IL-17A than the control group (<0.05), and the children with IVIG-resistant KD had a significantly higher serum level of IL-17A than those with IVIG-sensitive KD (<0.05). The receiver operating characteristic curve analysis showed that WBC, NE, CRP, and IL-17A had an area under the curve of 0.718, 0.741, 0.627, and 0.840, respectively, in the prediction of IVIG-resistant KD. With serum IL-17A ≥44.06 pg/mL as the cut-off value, IL-17A had a sensitivity of 84% and a specificity of 81% in the prediction of IVIG-resistant KD. The multivariate logistic regression analysis showed that a high serum level of IL-17A was a predictive factor for resistance to IVIG in children with KD (=1.161, =0.001).
Serum IL-17A levels are elevated in children with IVIG-resistant KD, and serum IL-17A level (≥44.06 pg/mL) may have a predictive value for resistance to IVIG in children with KD.
研究白细胞介素-17A(IL-17A)在静脉注射免疫球蛋白(IVIG)无反应性川崎病(KD)患儿血清中的表达及其临床意义。
选取2021年6月至2022年6月在华中科技大学同济医学院附属武汉儿童医院住院的143例KD患儿进行这项前瞻性研究,其中115例为IVIG敏感型KD,28例为IVIG无反应性KD。在匹配性别和年龄后,选取110例急性呼吸道感染性疾病患儿(发热时间≥5天但无KD)作为对照组。采用酶联免疫吸附测定法检测血清IL-17A水平。检测白细胞计数(WBC)、中性粒细胞计数(NE)、血小板计数、红细胞沉降率和C反应蛋白(CRP)水平。绘制受试者工作特征曲线,分析WBC、NE、CRP和IL-17A在预测IVIG无反应性KD中的价值。采用多因素logistic回归分析评估KD患儿对IVIG耐药的预测因素。
IVIG治疗前,KD组血清IL-17A水平显著高于对照组(<0.05),IVIG无反应性KD患儿血清IL-17A水平显著高于IVIG敏感型KD患儿(<0.05)。受试者工作特征曲线分析显示,WBC、NE、CRP和IL-17A在预测IVIG无反应性KD时的曲线下面积分别为0.718、0.741、0.627和0.840。以血清IL-17A≥44.06 pg/mL为临界值,IL-17A预测IVIG无反应性KD的灵敏度为84%,特异度为81%。多因素logistic回归分析显示,血清IL-17A水平升高是KD患儿对IVIG耐药的预测因素(=1.161,=0.001)。
IVIG无反应性KD患儿血清IL-17A水平升高,血清IL-17A水平(≥44.06 pg/mL)可能对KD患儿IVIG耐药具有预测价值。